Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Sussman, Norman
and
Ginsberg, David
1999.
Effects of Psychotropic Drugs on Weight.
Psychiatric Annals,
Vol. 29,
Issue. 10,
p.
580.
Naber, D.
and
Lambert, M.
1999.
Atypische Neuroleptika.
p.
1.
Bagnall, Anne-Marie
Kleijnen, Jos
Leitner, Maria
and
Lewis, Ruth
2000.
Ziprasidone for schizophrenia and severe mental illness.
Cochrane Database of Systematic Reviews,
Möller, Hans-Jürgen
2000.
Definition, Psychopharmacological Basis and Clinical Evaluation of Novel/Atypical Neuroleptics: Methodological Issues and Clinical Consequences.
The World Journal of Biological Psychiatry,
Vol. 1,
Issue. 2,
p.
75.
Goldberg, Richard J.
2001.
Weight Variance Associated with Atypical Neuroleptics in Nursing Home Dementia Patients.
Journal of the American Medical Directors Association,
Vol. 2,
Issue. 1,
p.
26.
2009.
Meyler's Side Effects of Endocrine and Metabolic Drugs.
p.
571.
2009.
Meyler's Side Effects of Psychiatric Drugs.
p.
185.
Ibragimov, Khasan
Keane, Gregory Peter
Carreño Glaría, Cristina
Cheng, Jie
and
Llosa, Augusto Eduardo
2024.
Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders.
Cochrane Database of Systematic Reviews,
Vol. 2024,
Issue. 7,
Comments
No Comments have been published for this article.